The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Testosterone suppression: Impact of testosterone level on disease progression in advanced prostate cancer.
Shawn Dason
No relevant relationships to disclose
Justin Tong
No relevant relationships to disclose
Christopher Brian Allard
No relevant relationships to disclose
Bobby Shayegan
No relevant relationships to disclose